[{"id":"88f5020d-8814-488d-b3cb-c97d3b33e81f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05155189","created_at":"2021-12-13T14:12:43.066Z","updated_at":"2024-07-02T16:35:11.399Z","phase":"Phase 1","brief_title":"A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma","source_id_and_acronym":"NCT05155189","lead_sponsor":"Zhejiang University","biomarkers":" GPC3","pipe":" | ","alterations":" GPC3 expression","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Lenvima (lenvatinib) • AZD7003"],"overall_status":"Recruiting","enrollment":" Enrollment 44","initiation":"Initiation: 12/09/2021","start_date":" 12/09/2021","primary_txt":" Primary completion: 05/01/2026","primary_completion_date":" 05/01/2026","study_txt":" Completion: 05/01/2041","study_completion_date":" 05/01/2041","last_update_posted":"2024-04-04"}]